CLASS II ONGOING Device recall · Reported 26 Aug 2026 · FDA Enforcement Report

TD Navio Maxi Speech Generating Device recalled by Tobii Dynavox

Tobii Dynavox is recalling TD Navio Maxi Speech Generating Device, distributed nationwide in the US. The recall was initiated on 8 Jul 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI 073400747602070 Serial Numbers TDNL1-240904000016 through TDNL1-260617070001. Corrected/future production is differentiated by new serialization from TDNL1-260617070001 onward (production batch 20260615, improved design).

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2960-2026
FDA event ID
99410
Recalling firm
Tobii Dynavox, Pittsburgh, PA
Classification
Class II
Status
Ongoing
Recall initiated
8 Jul 2026
FDA classified
14 Aug 2026
Reported
26 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

8 Jul 2026Recall initiated by company
14 Aug 2026Classified by FDA+37 days
26 Aug 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and gas venting within the device enclosure.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

TD Navio Maxi Speech Generating Device Model/Catalog Number: 1000799

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and gas venting within the device enclosure.

Which lots are affected?

UDI-DI 073400747602070 Serial Numbers TDNL1-240904000016 through TDNL1-260617070001. Corrected/future production is differentiated by new serialization from TDNL1-260617070001 onward (production batch 20260615, improved design).

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 99410

This product is part of a recall event; the main page for the event is TD Navio Midi Speech Generating Device recalled by Tobii Dynavox.

ReportedClassRecallCompanyReasonWhere
CLASS IITD Navio Midi Speech Generating Device recalled by Tobii DynavoxTobii DynavoxDevice MalfunctionNationwide

More recalls from Tobii Dynavox

All 3

Other Other Medical Devices recalls

All 13,986